Understanding knowledge, practices, and barriers in pediatric weight-management: a multisite cross-sectional study of

Joshua S Yudkin1, Kristy Marie Polanco Lima2, Jenny L Cepeda-Marte2

  • 1Texas A&M University, School of Public Health, College Station, TX, USA. yudkin@tamu.edu.

Pediatric Research
|May 23, 2026
PubMed

Insights

Pediatric overweight and obesity management in the Dominican Republic shows provider confidence but gaps in knowledge and counseling. Targeted training and family-centered care are crucial for improving care in low-resource settings.

Area of Science:

  • Pediatric Endocrinology
  • Public Health
  • Clinical Practice Guidelines

Background:

  • Rising prevalence of pediatric overweight and obesity (OW/OB) in Latin America and the Caribbean.
  • OW/OB poses a significant global health challenge, particularly in low- and middle-income countries (LMICs).

Purpose of the Study:

  • To assess healthcare providers' knowledge, attitudes, and counseling practices regarding pediatric OW/OB management.
  • To identify barriers and facilitators to effective pediatric OW/OB care in a low-resource setting.

Main Methods:

  • Cross-sectional study conducted in 15 pediatric clinics in the Dominican Republic (January-March 2025).
  • Surveys assessed provider knowledge, attitudes, self-reported counseling behaviors, and perceptions of the clinical environment.
  • Descriptive statistics and multivariable regression analyses were employed.

Main Results:

  • High provider confidence in diagnosing OW/OB (93.2%) contrasted with knowledge gaps in definition (57.3%-75.3%).
  • Inconsistent counseling on family priorities (27.2%) and physical activity (62.1%) during well-child visits.
  • High referral rates to dietitians (91.3%) but low rates of consistent follow-up scheduling (51.5%).

Conclusions:

  • Significant gaps exist in provider knowledge and counseling practices for pediatric OW/OB.
  • Strengthening pediatric obesity management requires targeted training and enhanced support systems.
  • Family-centered care approaches are essential in resource-limited settings for sustainable pediatric obesity management.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Primary Healthcare Services01:30

Primary Healthcare Services

Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...